Calcitriol Ameliorates AngiotensinII-Induced Renal Injury Partly via Upregulating A20

Hongfei Zhao1, Yunfeng Xia1, Hua Gan2

  • 1Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing, 400016, China.

Inflammation
|July 27, 2017
PubMed

Insights

Calcitriol, a form of vitamin D, protects kidneys by increasing A20, which reduces inflammation and oxidative stress. This study clarifies vitamin D

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Biology

Background:

  • Chronic kidney diseases involve inflammation and reactive oxygen species (ROS).
  • Vitamin D (calcitriol) exhibits anti-inflammatory properties, but mechanisms remain unclear.
  • Angiotensin II (AngII) infusion models renal injury.

Purpose of the Study:

  • Investigate calcitriol's protective effects against AngII-induced renal injury.
  • Determine if calcitriol upregulates A20, a key anti-inflammatory protein.
  • Elucidate the role of A20 in calcitriol's renoprotective mechanism.

Main Methods:

  • AngII infusion in C57BL/6 mice.
  • Assessment of inflammatory cell infiltration (T lymphocytes, macrophages).
  • Measurement of A20, pro-inflammatory cytokines (PICs), ROS, and NF-κB activation.
  • In vitro studies using rat proximal tubular epithelial cells (NRK-52E).
  • A20 knockdown experiments.

Main Results:

  • Calcitriol reduced inflammatory cell infiltration, PICs, and ROS in AngII-treated mice.
  • Calcitriol upregulated A20, inhibited NF-κB activation, and suppressed the necroptotic pathway.
  • A20 induction occurred primarily in tubular epithelial cells.
  • In vitro, calcitriol upregulated A20, reducing PICs and ROS by suppressing NF-κB and necroptosis.
  • A20 knockdown partially diminished calcitriol's effects, but did not abrogate them.

Conclusions:

  • Calcitriol exerts renoprotective effects in AngII-induced renal injury.
  • A20 upregulation is a key mechanism mediating calcitriol's anti-inflammatory and antioxidant actions.
  • Calcitriol modulates NF-κB and necroptotic pathways, partly via A20, to protect kidney function.

Related Concept Videos

Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.8K
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.3K
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
531